Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura L Swystun

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Hematology. American Society of Hematology. Education Program|December 6, 2015
Using genetic diagnostics in hemophilia and von Willebrand diseaseLaura L Swystun, Paula James
Pharmacogenomics and Personalized Medicine|March 31, 2023
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic VariationLaura L Swystun, David Lillicrap
Blood|July 19, 2014
FVIII stabilization: VWF D'D3 will doLaura L Swystun, David Lillicrap
Current Opinion in Hematology|July 19, 2016
How much do we really know about von Willebrand disease?Laura L Swystun, David Lillicrap
Circulation Research|April 30, 2016
Gene Therapy for Coagulation DisordersLaura L Swystun, David Lillicrap
Blood Reviews|September 7, 2016
Genetic diagnosis in hemophilia and von Willebrand diseaseLaura L Swystun, Paula D James
Blood|June 30, 2016
The role of leukocytes in thrombosisLaura L Swystun, Patricia C Liaw
Journal of Thrombosis and Haemostasis : JTH|April 21, 2023
The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasisLaura L Swystun, Alison Michels, David Lillicrap
Therapeutic Advances in Hematology|February 2, 2026
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expressionSylvia Fong, Laura L Swystun, Paul Batty, et al.
Journal of Visualized Experiments : Jove|August 23, 2017
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String FormationAlison Michels, Laura L Swystun, Jeffrey Mewburn, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Hematology. American Society of Hematology. Education Program|December 6, 2015
Using genetic diagnostics in hemophilia and von Willebrand diseaseLaura L Swystun, Paula James
Pharmacogenomics and Personalized Medicine|March 31, 2023
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic VariationLaura L Swystun, David Lillicrap
Blood|July 19, 2014
FVIII stabilization: VWF D'D3 will doLaura L Swystun, David Lillicrap
Current Opinion in Hematology|July 19, 2016
How much do we really know about von Willebrand disease?Laura L Swystun, David Lillicrap
Circulation Research|April 30, 2016
Gene Therapy for Coagulation DisordersLaura L Swystun, David Lillicrap
Blood Reviews|September 7, 2016
Genetic diagnosis in hemophilia and von Willebrand diseaseLaura L Swystun, Paula D James
Blood|June 30, 2016
The role of leukocytes in thrombosisLaura L Swystun, Patricia C Liaw
Journal of Thrombosis and Haemostasis : JTH|April 21, 2023
The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasisLaura L Swystun, Alison Michels, David Lillicrap
Therapeutic Advances in Hematology|February 2, 2026
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expressionSylvia Fong, Laura L Swystun, Paul Batty, et al.
Journal of Visualized Experiments : Jove|August 23, 2017
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String FormationAlison Michels, Laura L Swystun, Jeffrey Mewburn, et al.
Pageof 4